Curious about therapeutic CRISPR delivery, and the potential of pre-formed RNP enzymes? Then I've got just the webinar for you! I review where we are and we're headed when it comes to non-viral delivery of editors like Cas9: youtu.be/_dOGxs2clJ0

Flashback to when Lorena and I tried to wear ALL the ⁦swag after a talk Synthego ⁦

If you’ve ever said “sorry this slide is so busy” I have massive news for you about who controls the content of your PowerPoint presentation

Planning my new fall curriculum. I'm pleased to announce a new online course that will teach people when to use "reply all" to respond to an e-mail message, and when just respond to the sender. Registration is open soon, so please sure to share. I know many people will benefit.

Join me at UC Berkeley in a short-term position to work on identifying shared genomic variation in COVID breakthrough cases. Joint work with Kaiser Permanente, Berkeley SPH and the CDPH and funded by the Rockefeller foundation. tinyurl.com/2stjnyfw

A model for diversifying faculty recruitment nature.com/articles/d4158…

The Lareau Lab at Berkeley is looking to recruit a wet lab postdoc interested in mRNA translation and more. Check out our website for an overview of our research. lareaulab.org

1. Major unlock of CRISPR potential empowered by metagenomics #NewMetaCRISPR. I’ve been hoping to see this happen for years: a way to edit the genomes of microorganisms within communities

Update: The CDC still recommends not asking graduate students how long they have left until they graduate.

Bittersweet to announce I have finished my postdoc Ross Wilson and Institute for Geographic Information Science and am starting a new adventure Related Sciences! It’s been such a special 4 years of RNP delivery & chocolate covered pretzels 🥨 Stay tuned for our upcoming preprint!

Donate to support the Ukrainian Red Cross and its work to help civilians in this difficult time for Ukraine! You can donate on ✅ URCS website: redcross.org.ua/donate/ ✅ iRaiser platform: donate.redcrossredcrescent.org/ua/donate/ 📢 Please share! #SupportUkraine #Ukraine #URCS #DonateUkraine

Great morning talk in the nonviral delivery session by Ross Wilson on “Peptide-enabled CRISPR enzyme delivery for immune cell engineering” 👏🏻🧫⚗️ #ASGCT22

Very excited to share our report out Nature Biomedical Engineering which is the result of my postdoc work Ross Wilson Institute for Geographic Information Science UC Berkeley. Very grateful to co-first authors David Nguyen from @MarsonLab and Joe Muldoon from Justin Eyquem lab UC San Francisco, as well as the *whole team* who made it all possible!!

Thanks as always to the fantastic #scicomm team @igisci for this summary of our recent published work Ross Wilson , giving context and take-home impacts that are approachable for a general audience! Please check out this write up linked below.

Excited to highlight Nature Biomedical Engineering cover story on PERC, peptide-based delivery of #CRISPR RNPs into T cells for ex vivo gene editing with reduced toxicity vs. electroporation. Great work from dana foss et al. Ross Wilson Justin Eyquem @MarsonLab #CARTcell rdcu.be/dcw3w

We made the cover Nature Biomedical Engineering with our recent work from my postdoc Ross Wilson @igisci UC Berkeley Congrats to the whole team who contributed to this work!!!

Nice explanation of the benefits of the emerging hub-and-spoke model in biotech! nasdaq.com/articles/how-t…

Crazy—we took a quick look at our platform data to see if it supported how it "feels" out there. 2024 is on trend for the lowest programs against "new drug targets" in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new